AMN Healthcare Services’ third quarter was marked by a positive market reaction, reflecting stronger-than-expected results despite a year-on-year revenue decline. Management attributed the quarter’s outcome to a moderate recovery in staffing demand, improved extension rates, and higher-than-expected labor disruption activity—especially in Nurse and Allied Solutions. CEO Caroline Grace highlighted that “extension rates rebounded, and Travel Nurse winter orders came in slightly favorable to prior year,” while permanent hiring activity in the healthcare sector contracted. The company also benefited from stable bill rates and operational execution that mitigated some of the softness in underlying sales volumes.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN)
fell 0.9% in the afternoon session after investors looked past a third-quarter earnings beat and focused on significant year-over-year declines in revenue and profits.
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 7.7% year on year to $634.5 million. On top of that, next quarter’s revenue guidance ($722.5 million at the midpoint) was surprisingly good and 16.4% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 95.2% above analysts’ consensus estimates.
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 7.7% year on year to $634.5 million. On top of that, next quarter’s revenue guidance ($722.5 million at the midpoint) was surprisingly good and 16.4% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 95.2% above analysts’ consensus estimates.
AMN Healthcare Services currently trades at $20.73 per share and has shown little upside over the past six months, posting a middling return of 2.8%. The stock also fell short of the S&P 500’s 23.9% gain during that period.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN)
jumped 3.2% in the afternoon session after Truist Securities reiterated its "Buy" rating and increased its price target on the company's stock. The firm's analyst, Tobey Sommer, lifted the target by 20% to $24.00 from a previous $20.00. This adjustment pointed to a positive outlook on the company's future performance. The move provided a notable point of optimism, especially when viewed against the wider analyst consensus which had previously set an average price target of $20.00 for the stock.
Washington D.C. – October 10, 2025 – Federal Reserve Governor Christopher Waller delivered a stark warning today, Friday, October 10, 2025, sending ripples through financial markets with his assertion of "negative job growth" and a significantly stalling U.S. labor market. Speaking on CNBC's "Squawk Box," Waller’s remarks underscore a
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025. This concerning assessment comes at a critical juncture for the economy, compounded by an ongoing federal government
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series of White House initiatives and legislative actions, most notably the ongoing implementation of the Inflation Reduction Act (IRA) and the pursuit
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a broader market optimism rippling through the healthcare sector. While AMN's direct stock drivers often stem from company-specific operational successes, today's surge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing agreement reached between the White House and a major pharmaceutical player, Pfizer (NYSE: PFE). This development has been widely interpreted by investors as
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN)
fell 6.2% in the afternoon session after Bank of America Securities lowered its price target on the stock from $20.00 to $18.00.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
